Cambrex makes 'Pharma 3' plant operational after equipment delivery delays

By Gareth Macdonald contact

- Last updated on GMT

Cambrex's Pharma 3 facility in Charles City, Iowa
Cambrex's Pharma 3 facility in Charles City, Iowa

Related tags: Capacity utilization, Delay, Tom delay

Cambrex has brought a delayed Iowa API facility online and completed work on a shell plant that can be tailored to specific projects. 

The US contract manufacturing organisation (CMO) announced that the facility – known as Pharma 3 - in Charles City, Iowa became fully operational after the completion of validation work last month.

Plans for Pharma 3 were announced last February when Cambrex predicted it would be up and running “early” this year.

However, in May the firm announced a delay citing late equipment deliveries and installation challenges.

A spokesman told us “While delays in equipment delivery and a few installation challenges caused us to push the start-up date back, we successfully adjusted the site's production schedule to ensure that we continue to meet customer demand and the facility is now fully operational​.”

Pharma 4

Cambrex has also constructed a manufacturing shell – Pharma 4 - that can be fitted out in response to specific project needs.

In April CFO Greg Sargen who told investors Pharma 4 would not be made operational before 2017.

We'll get Pharma 3 up and running and see how that acceleration of the capacity utilization goes, see how orders come in on the back half of the year, see how some of our late stage projects progress.

And probably towards the end of this year or early 2017 we'll have a much better bead on timing of Pharma 4​.”

According to Cambrex’ first quarter results revenue for the three months to March increased 20% to $93.9m (€81.7m) due to higher demand for APIs.

Margins also improved – from 37% to 41% - thanks in part to higher capacity utilization. Operating profit increased from $12.7 to $21.4m.

Related news

Show more

Related products

show more

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Related suppliers

Follow us


View more